Otis Worldwide CapEx decreased by 26.7% to $33.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.9%, from $34.00M to $33.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a -0.6% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.00M | $31.00M | $41.00M | $30.00M | $27.00M | $24.00M | $34.00M | $25.00M | $37.00M | $34.00M | $42.00M | $31.00M | $24.00M | $32.00M | $39.00M | $34.00M | $36.00M | $37.00M | $45.00M | $33.00M |
| QoQ Change | — | -22.5% | +32.3% | -26.8% | -10.0% | -11.1% | +41.7% | -26.5% | +48.0% | -8.1% | +23.5% | -26.2% | -22.6% | +33.3% | +21.9% | -12.8% | +5.9% | +2.8% | +21.6% | -26.7% |
| YoY Change | — | — | — | — | -32.5% | -22.6% | -17.1% | -16.7% | +37.0% | +41.7% | +23.5% | +24.0% | -35.1% | -5.9% | -7.1% | +9.7% | +50.0% | +15.6% | +15.4% | -2.9% |